Abnormal presence of the matrix extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif peptide in human hypophosphatemic dentin

American Journal of Pathology

Volumn 177, Issue 2, 2010, Pages 803-812

  Boukpessi, Tchilalo ^a,b   Gaucher, Celine ^a,b,c   Léger, Thibaut ^d   Salmon, Benjamin ^a,b   Le Faouder, Julie ^e   Willig, Cyril ^a   Rowe, Peter S ^f   Garabédian, Michèle ^c   Meilhac, Olivier ^d   Chaussain, Catherine ^a,b  

^a and Plateforme d'Imagerie du Vivant   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c HÔPITAL SAINT VINCENT DE PAUL   (France)

^d INSERM   (France)

^e BICHAT HOSPITAL   (France)

^f UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; DENTIN MATRIX PROTEIN 1; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; PHOSPHATE; SERINE; VITAMIN D;

ARTICLE; CONTROLLED STUDY; DENTIN; FEMALE; HUMAN; HYPOPHOSPHATEMIA; IMMUNOPRECIPITATION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINERALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MOTIF; PROTEOMICS; RAT; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; WESTERN BLOTTING; X CHROMOSOME;

EID: 77957288774     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.091231     Document Type: Article

References (33)

1. Rowe PS, Oudet CL, Francis F, Sinding C, Pannetier S, Econs MJ, Strom TM, Meitinger T, Garabedian M, David A, Macher MA, Questiaux E, Popowska E, Pronicka E, Read AP, Mokrzycki A, Glorieux FH, Drezner MK, Hanauer A, Lehrach H, Goulding JN, O'Riordan JL: Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). Hum Mol Genet 1997, 6:539-549
2. Rowe PS: The role of the PHEX gene (PEX) in families with X-linked hypophosphataemic rickets. Curr Opin Nephrol Hypertens 1998, 7:367-376
3. Bowe AE, Finnegan R, Jan de Beur SM, Cho J, Levine MA, Kumar R, Schiavi SC: FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. Biochem Biophys Res Commun 2001, 284:977-981
4. Campos M, Couture C, Hirata IY, Juliano MA, Loisel TP, Crine P, Juliano L, Boileau G, Carmona AK: Human recombinant endopeptidase PHEX has a strict S1′ specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein. Biochem J 2003, 373:271-279
5. Liu S, Guo R, Simpson LG, Xiao ZS, Burnham CE, Quarles LD: Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 2003, 278:37419-37426
6. Chaussain-Miller C, Sinding C, Septier D, Wolikow M, Goldberg M, Garabedian M: Dentin structure in familial hypophosphatemic rickets: benefits of vitamin D and phosphate treatment. Oral Dis 2007, 13:482-489
7. Chaussain-Miller C, Sinding C, Wolikow M, Lasfargues JJ, Godeau G, Garabedian M: Dental abnormalities in patients with familial hypophosphatemic vitamin D-resistant rickets: prevention by early treatment with 1-hydroxyvitamin D. J Pediatr 2003, 142:324-331
8. Rowe PS, de Zoysa PA, Dong R, Wang HR, White KE, Econs MJ, Oudet CL: MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia. Genomics 2000, 67:54-68
9. Argiro L, Desbarats M, Glorieux FH, Ecarot B: Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone. Genomics 2001, 74:342-351
10. Gowen LC, Petersen DN, Mansolf AL, Qi H, Stock JL, Tkalcevic GT, Simmons HA, Crawford DT, Chidsey-Frink KL, Ke HZ, McNeish JD, Brown TA: Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 2003, 278:1998-2007
11. Quarles LD: FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization, Am J Physiol Endocrinol Metab 2003, 285:E1-E9
12. MacDougall M, Simmons D, Gu TT, Dong J: MEPE/OF45, a new dentin/bone matrix protein and candidate gene for dentin diseases mapping to chromosome 4q21. Connect Tissue Res 2002, 43: 320-330
13. Liu H, Li W, Shi S, Habelitz S, Gao C, Denbesten P: MEPE is downregulated as dental pulp stem cells differentiate. Arch Oral Biol 2005, 50:923-928 (Pubitemid 41393049)
14. Fisher LW, Fedarko NS: Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res 2003, 44(Suppl 1):33-40
15. Qin C, Baba O, Butler WT: Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Crit Rev Oral Biol Med 2004, 15:126-136
16. Liu S, Brown TA, Zhou J, Xiao ZS, Awad H, Guilak F, Quarles LD: Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia. J Am Soc Nephrol 2005, 16:1645-1653
17. Rowe PS, Garrett IR, Schwarz PM, Carnes DL, Lafer EM, Mundy GR, Gutierrez GE: Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP). Bone 2005, 36:33-46
18. Rowe PS: The wrickkened pathways of FGF23, MEPE and PHEX. Crit Rev Oral Biol Med 2004, 15:264-281
19. Bresler D, Bruder J, Mohnike K, Fraser WD, Rowe PS: Serum MEPE-ASARM- peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and rickets. J Endocrinol 2004, 183:R1-R9
20. Boukpessi T, Septier D, Bagga S, Garabedian M, Goldberg M, Chaussain-Miller C: Dentin alteration of deciduous teeth in human hypophosphatemic rickets. Calcif Tissue Int 2006, 79:294-300
21. Gaucher C, Walrant-Debray O, Nguyen TM, Esterle L, Garabedian M, Jehan F: PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets. Hum Genet 2009, 125:401-411
22. Martin A, David V, Laurence JS, Schwarz PM, Lafer EM, Hedge AM, Rowe PS: Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP. Endocrinology 2008, 149:1757-1772
23. Boukpessi T, Menashi S, Camoin L, Tencate JM, Goldberg M, Chaussain- Miller C: The effect of stromelysin-1 (MMP-3) on non-collagenous extracellular matrix proteins of demineralized dentin and the adhesive properties of restorative resins. Biomaterials 2008, 29:4367-4373
24. Guo R, Rowe PS, Liu S, Simpson LG, Xiao ZS, Quarles LD: Inhibition of MEPE cleavage by Phex. Biochem Biophys Res Commun 2002, 297:38-45
25. Chaussain C, Eapen AS, Huet E, Floris C, Ravindran S, Hao J, Menashi S, George A: MMP2-cleavage of DMP1 generates a bioactive peptide promoting differentiation of dental pulp stem/progenitor cell. Eur Cell Mater 2009, 18:84-95
26. Six N, Septier D, Chaussain-Miller C, Blacher R, DenBesten P, Goldberg M: Dentonin, a MEPE fragment, initiates pulp-healing response to injury. J Dent Res 2007, 86:780-785
27. Addison WN, Nakano Y, Loisel T, Crine P, McKee MD: MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM. J Bone Miner Res 2008, 23:1638-1649
28. Rowe PS, Matsumoto N, Jo OD, Shih RN, Oconnor J, Roudier MP, Bain S, Liu S, Harrison J, Yanagawa N: Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin. Bone 2006, 39:773-786
29. David V, Martin A, Hedge AM, Rowe PS: Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator. Endocrinology 2009, 150:4012-4023
30. Marks J, Churchill LJ, Debnam ES, Unwin RJ: Matrix extracellular phosphoglycoprotein inhibits phosphate transport. J Am Soc Nephrol 2008, 19:2313-2320
31. Addison W, Masica D, Gray J, McKee MD: Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage. J Bone Miner Res 2009, 25:695-705
32. Gaucher C, Boukpessi T, Septier D, Jehan F, Rowe PS, Garabedian M, Goldberg M, Chaussain-Miller C: Dentin noncollagenous matrix proteins in familial hypophosphatemic rickets. Cells Tissues Organs 2009, 189:219-223
33. Rowe PS, Kumagai Y, Gutierrez G, Garrett IR, Blacher R, Rosen D, Cundy J, Navvab S, Chen D, Drezner MK, Quarles LD, Mundy GR: MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone 2004, 34:303-319